Search Results

You are looking at 61 - 70 of 85 items for :

  • Refine by Access: All content x
Clear All
Open access

Dorte Glintborg, Katrine Hass Rubin, Mads Nybo, Bo Abrahamsen, and Marianne Andersen

autoantibody change: a longitudinal population-based study . Thyroid 2016 203 – 211 . ( ) 26711373 31 Glintborg D Mumm H Holst JJ Andersen M . Effect of oral contraceptives and/or metformin on GLP-1

Open access

Julia Modesto Vicente, Junia Carolina Santos-Silva, Caio Jordão Teixeira, Dailson Nogueira de Souza, Jean Franciesco Vettorazzi, Fabiola Sales Furtuoso, Isabel Gouveia Adabo, Fabio Takeo Sato, Marco Aurélio Ramirez Vinolo, Everardo Magalhães Carneiro, Silvana Bordin, and Gabriel Forato Anhê

both neurotransmitters released during the cephalic phase of insulin release or incretins such as glucagon-like peptide 1 (GLP-1) and gastric inhibitory peptide (GIP) released by enteroendocrine cells in response to food transit ( 26 ). Human islets are

Open access

Florian W Kiefer

activity. However, the effects were not sufficient to induce a loss of body weight or fat mass ( 59 ). In contrast, treatment with the antidiabetic agent liraglutide, which acts as an agonist at the glucagon-like peptide-1 (GLP-1) receptor results in

Open access

David Koeckerling, Jeremy W Tomlinson, and Jeremy F Cobbold

greater, more sustained weight loss than other procedures with almost immediate, weight-independent effects on glycaemic control, insulin sensitivity and GLP-1 secretion ( 45 , 69 ). Sleeve gastrectomy produces less marked, but comparable, effects to Roux

Open access

J Van Schaik, M Burghard, M H Lequin, E A van Maren, A M van Dijk, T Takken, L B Rehorst-Kleinlugtenbelt, B Bakker, L Meijer, E W Hoving, M Fiocco, A Y N Schouten-van Meeteren, W J E Tissing, and H M van Santen

GLP-1. Additionally, the disruption of autonomic function damages the biologic clock and therefore the circadian activity ( 13 ). Next to energy balance, the hypothalamus also plays an essential role in the body’s temperature regulation, thirst

Open access

Aldo Bonaventura, Fabrizio Montecucco, and Franco Dallegri

.1517/14740338.2012.694424 ). 78 Aroda VR Henry RR Han J Huang W DeYoung MB Darsow T Hoogwerf BJ . Efficacy of GLP-1 receptor agonists and DPP-4 inhibitors: meta-analysis and systematic review . Clinical Therapeutics 2012 34 1247 – 1258 . ( doi:10.1016/j

Open access

Hugo R Ramos, Andreas L Birkenfeld, and Adolfo J de Bold

(125) ; an observation that seems to depend on the amount of weight loss (126, 127) . Experimental data further suggests that the incretin glucagon like peptide 1 (GLP1) might be of relevance in the regulation of NP secretion. The GLP1 receptor agonist

Open access

Jan Kvasnička, Ondřej Petrák, Tomáš Zelinka, Judita Klímová, Barbora Kološová, Květoslav Novák, David Michalský, Jiří Widimský Jr, and Robert Holaj

-associated chromaffin tissue (PGLs) ( 1 ). Both types of tumours are collectively referred to as PPGLs. The prevalence of PHEO and PGLs in non-selected population of patients with arterial hypertension is between 0.2 and 0.6% ( 2 , 3 ). The prevalence of PHEO is higher

Open access

Irvin M Modlin, Harry Aslanian, Lisa Bodei, Ignat Drozdov, and Mark Kidd

cell tumors), as well as small intestinal ‘carcinoids’ (secretin, serotonin, and a variety of tachykinins) and colorectal lesions (enteroglucagon, GLP1, and pancreatic polypeptide (PP)). The conundrum of identifying a global marker for NETs therefore

Open access

Carolina Inda, Natalia G Armando, Paula A dos Santos Claro, and Susana Silberstein

signaling pathway. However, this persistent signaling has been subsequently reported for other GPCRs, including peptide hormone receptors, such as glucagon-like peptide 1 receptor (GLP1R) ( 167 ), pituitary adenylate cyclase activating polypeptide (PACAP